ADVERUM BIOTECHNOLOGIES: Istoricul versiunilor

29 septembrie 2024

• actualăprec 02:0529 septembrie 2024 02:05‎ 127.0.0.1 discuție‎ 1.436 de octeți +4‎ The LinkTitles extension automatically added links to existing pages (https://github.com/bovender/LinkTitles). anulare

18 septembrie 2024

• actualăprec 15:3518 septembrie 2024 15:35‎ Admin discuție contribuții‎ 1.432 de octeți +1.432‎ Pagină nouă: Pagina dedicata companiei ADVERUM BIOTECHNOLOGIES listata cu simbolul US.ADVM ==Descriere companie== Adverum Biotechnologies, Inc. (https://adverum.com/) is a clinical-stage gene therapy company targeting ocular and rare diseases. It develops gene therapy product candidates. Its ADVM-022, is a clinical-stage gene therapy product candidate developed for the treatment of wet age-related macular degeneration (AMD) and diabetic macular edema (DME). ADVM-022, is given as a one-ti...